Previously lecanemab was only approved as an SC injection for maintenance dosing, following an initial 18 month IV phase.

Several medical societies backed the 2026 AAP childhood vaccine schedule, prioritizing longstanding scientific evidence for pediatric public health protocols.

Afrezza is a rapid-acting inhaled human insulin indicated to improve glycemic control in adults with diabetes mellitus.

The between-group difference in restricted mean arthritis-free survival time seen at 2 years persisted at 4 years.

HealthDay News — Six-month smartwatch-based atrial fibrillation (AF) screening improves detection of new-onset AF among patients at elevated stroke risk, according to a study published online January ...